| CXSL1800028 | 重组抗PD-L1全人源单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-03-26 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2018-08-07 | view |
| CXSL1600075 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2016-10-11 | 基石药业（苏州）有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2017-07-17 | view |
| CXSL1900143 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-12-20 | 基石药业（苏州）有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-12-18 | view |
| CXSL1700206 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-02-13 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2018-07-13 | view |
| CXSL1900017 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-03-07 | 基石药业（苏州）有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-03-06 | view |
| CXSL1900011 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-02-12 | 基石药业（苏州）有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2019-02-11 | view |
| CXSB1800001 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products | Supplementary Application | 2018-01-26 | 基石药业（苏州）有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL2000015 | 重组抗PD-L1全人单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-02-10 | 基石药业（苏州）有限公司 | Cornerstone Pharmaceutical (Suzhou) Co Ltd | In Review | 2020-02-07 | view |
| CXSL2000354 | 重组全人抗PD-L1单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-12-16 | 兆科（广州）肿瘤药物有限公司 | Zhaoke (Guangzhou) Oncology Pharmaceutical Limited | In Review | 2020-12-14 | view |
| CXSL2000130 | 重组全人抗PD-L1单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-07-15 | 兆科（广州）肿瘤药物有限公司 | Zhaoke (Guangzhou) Oncology Pharmaceutical Limited | In Review | 2020-07-13 | view |
| CXSL1700004 | 重组全人抗PD-L1单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2017-05-17 | 兆科（广州）肿瘤药物有限公司 | Zhaoke (Guangzhou) Oncology Pharmaceutical Limited | Certificate Issued | 2018-01-17 | view |
| CXSL2000201 | 全人源抗PD-L1抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-07-14 | 宝船生物医药科技(上海)有限公司 | Baochuan Biological Medicine Technology (Shanghai) Co Ltd | In Review | 2020-07-13 | view |
| CXSL1800090 | 全人源抗PD-L1抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-08-30 | 白帆生物科技（上海）有限公司 | Dragon Sail Pharmaceutical Co Ltd | Certificate Issued | 2018-11-01 | view |
| CXSL2101356 | 全人源抗PD-L1抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-10-14 | | Baochuan Biological Medicine Technology (Shanghai) Co Ltd | | | view |
